[Efficacy of 48-hour infusion of 5-fluorouracil for gall bladder cancer]

Gan To Kagaku Ryoho. 1993 Dec;20(15):2341-4.
[Article in Japanese]

Abstract

Usefulness of an adjuvant chemotherapy for 23 patients who had undergone "non-curative" resection for adenocarcinomas of the gallbladder was investigated. Patients were divided into two groups: Group A (16 patients) was given MF (mitomycin C 6 mg/m2, 5-fluorouracil 250 mg/body) by injection on the 2nd and 9th postoperative day and received orally Tegafur 600 mg/day and PSK 3 g/day. Group B(7 patients) was treated weekly with a 48-hour infusion of 5-FU (1,000 mg/m2/24 hours), for 6 weeks and leucovorin (30 mg/body) was given for 2 hours prior to 5-FU infusion. The results were evaluated by the Kaplan-Meier method. Response rate of anti-tumor was 0% in Group A and 14.3% in Group B, including: PR, 1 and NC, 6 cases. The 50% survival time was 230 days in group A and 471 days in group B (p = 0.0008). The results suggest that treatment with 5-FU and LV is effective for gallbladder cancer.

Publication types

  • Case Reports
  • Comparative Study

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / mortality
  • Adenocarcinoma / surgery
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chemotherapy, Adjuvant
  • Drug Administration Schedule
  • Drug Evaluation
  • Female
  • Fluorouracil / administration & dosage*
  • Fluorouracil / therapeutic use
  • Gallbladder Neoplasms / drug therapy*
  • Gallbladder Neoplasms / mortality
  • Gallbladder Neoplasms / surgery
  • Humans
  • Infusions, Intravenous / methods
  • Leucovorin / therapeutic use
  • Male
  • Middle Aged
  • Mitomycin / administration & dosage
  • Proteoglycans / administration & dosage
  • Remission Induction
  • Survival Rate
  • Tegafur / administration & dosage

Substances

  • Proteoglycans
  • Tegafur
  • polysaccharide-K
  • Mitomycin
  • Leucovorin
  • Fluorouracil